BIOMAT Database Logo BIOMAT Database Logo

[Nonpeptide angiotensin II antagonists]. 1992

H Shionoiri, and I Takasaki, and K Sugimoto, and K Minamisawa
Second Department of Internal Medicine, Yokohama City University School of Medicine.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D001713 Biphenyl Compounds Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings. Compounds, Biphenyl
D013777 Tetrazoles
D057911 Angiotensin Receptor Antagonists Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR. Angiotensin II Receptor Antagonist,Angiotensin II Receptor Blocker,Angiotensin Receptor Antagonist,Angiotensin Receptor Blocker,Angiotensin II Receptor Antagonists,Angiotensin II Receptor Blockers,Angiotensin Receptor Blockers,Antagonist, Angiotensin Receptor,Antagonists, Angiotensin Receptor,Blocker, Angiotensin Receptor,Receptor Antagonist, Angiotensin,Receptor Antagonists, Angiotensin,Receptor Blocker, Angiotensin,Receptor Blockers, Angiotensin
D019808 Losartan An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II. 2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol,Cozaar,DuP-753,Losartan Monopotassium Salt,Losartan Potassium,MK-954,MK954,DuP 753,DuP753,MK 954,Monopotassium Salt, Losartan,Potassium, Losartan,Salt, Losartan Monopotassium

Related Publications

H Shionoiri, and I Takasaki, and K Sugimoto, and K Minamisawa
Nonpeptide angiotensin II receptor antagonists.
August 1990, American journal of hypertension,
H Shionoiri, and I Takasaki, and K Sugimoto, and K Minamisawa
[Nonpeptide angiotensin II-receptor antagonists].
September 1994, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
H Shionoiri, and I Takasaki, and K Sugimoto, and K Minamisawa
[Nonpeptide angiotensin II receptor antagonists].
August 1993, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
H Shionoiri, and I Takasaki, and K Sugimoto, and K Minamisawa
Nonpeptide angiotensin II receptor antagonists.
February 1991, Trends in pharmacological sciences,
H Shionoiri, and I Takasaki, and K Sugimoto, and K Minamisawa
Nonpeptide angiotensin II receptor antagonists. Introduction.
April 1991, American journal of hypertension,
H Shionoiri, and I Takasaki, and K Sugimoto, and K Minamisawa
Pharmacology of nonpeptide angiotensin II receptor antagonists.
January 1992, Annual review of pharmacology and toxicology,
H Shionoiri, and I Takasaki, and K Sugimoto, and K Minamisawa
Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists.
January 1993, Journal of medicinal chemistry,
H Shionoiri, and I Takasaki, and K Sugimoto, and K Minamisawa
Nonpeptide angiotensin II receptor antagonists. IV. EXP6155 and EXP6803.
May 1989, Hypertension (Dallas, Tex. : 1979),
H Shionoiri, and I Takasaki, and K Sugimoto, and K Minamisawa
Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
September 1989, The Journal of pharmacology and experimental therapeutics,
H Shionoiri, and I Takasaki, and K Sugimoto, and K Minamisawa
4-(Heteroarylthio)-2-biphenylyltetrazoles as nonpeptide angiotensin II antagonists.
November 1995, Journal of medicinal chemistry,
Copied contents to your clipboard!